Methylomic signature of lithium response in bipolar disorder

被引:0
|
作者
Bourdon, C. [1 ]
Courtin, C. [1 ]
Bellivier, F. [1 ,2 ,3 ]
Etain, B. [1 ,2 ,3 ]
Marie-Claire, C. [1 ]
机构
[1] Univ Paris Cite, INSERM, Optimisat Therapeut Neuropsychopharmacol, Creteil, France
[2] Univ Paris, Hop Lariboisiere Fernand Widal, GHU APHP Nord, Dept Psychiat & Med Addictol, Paris, France
[3] Fdn Fondamental, Creteil, France
关键词
D O I
10.1192/j.eurpsy.2024.468
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
EPP0285
引用
收藏
页码:S218 / S219
页数:2
相关论文
共 50 条
  • [31] Methylomic and transcriptomic biosignatures of suicide death in the brains of individuals with bipolar disorder
    Lima, Camila Nayane De Carvalho
    Mirza, Salahudeen
    Rubinstein, Alexandre
    Kluwe-Schiavon, Bruno
    Busby, Christopher
    Stertz, Laura
    Jha, Rohit
    Del Favero-Campbell, Alexandra
    Kumar, Apurva
    Farhan, Mohammad
    Soyebo, Esther
    Quevedo, Joao
    Walss-Bass, Consuelo
    Soares, Jair C.
    Fries, Gabriel R.
    BIPOLAR DISORDERS, 2024, 26 : 39 - 40
  • [32] Lithium response in bipolar disorder: Ethnicity as a major predictor of treatment response
    Diaz-Zuluaga, Ana M.
    Cuartas, Mauricio
    Arcos-Burgos, Mauricio
    Vargas, Cristian
    Murcia, Cristian C.
    Velez, Jorge I.
    Palacio, Juan D.
    Jaramillo, Carlos L.
    BIPOLAR DISORDERS, 2020, 22 : 107 - 107
  • [33] A DNA methylation signature discriminates between excellent and non-response to lithium in patients with bipolar disorder type 1
    C. Marie-Claire
    F. X. Lejeune
    E. Mundwiller
    D. Ulveling
    I. Moszer
    F. Bellivier
    B. Etain
    Scientific Reports, 10
  • [34] A Dna Methylation Signature Discriminates Between Excellent and Non-Response to Lithium in Patients With Bipolar Disorder Type 1
    Marie-Claire, Cynthia
    Lejeune, Francois-Xavier
    Bellivier, Frank
    Etain, Bruno
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S13 - S14
  • [35] A DNA methylation signature discriminates between excellent and non-response to lithium in patients with bipolar disorder type 1
    Marie-Claire, C.
    Lejeune, F. X.
    Mundwiller, E.
    Ulveling, D.
    Moszer, I.
    Bellivier, F.
    Etain, B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] Ethnicity as a Major Predictor of Lithium Response in the Treatment of Bipolar Disorder
    Diaz-Zuluaga, Ana M.
    Cuartas, Mauricio
    Arcos-Burgos, Mauricio
    Vargas, Cristian
    Velez, Jorge I.
    Lopez-Jaramillo, Carlos
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 453 - 454
  • [37] Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder
    Herrera-Rivero, Marisol
    Gutierrez-Fragoso, Karina
    Kurtz, Joachim
    Baune, Bernhard T.
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01)
  • [38] Predictors of response to lithium and lamotrigine prophylaxis in bipolar I disorder
    Ketter, T
    Bowden, C
    Vieta, E
    Goldberg, JF
    Antonijevic, Z
    Leadbetter, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S267 - S267
  • [39] fMRI Correlates of Lithium Response: A Pilot Study in Bipolar Disorder
    Rootes-Murdy, Kelly
    Glazer, Kara
    Goes, Fernando
    Mondimore, Francis
    Zandi, Peter
    DePaulo, J. Raymond, Jr.
    Bakker, Arnold
    Mahon, Pamela
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S546 - S546
  • [40] Pharmacogenetic study of lithium response in Mexican bipolar disorder patients
    Ortega, O. H.
    Palacios, R.
    Camarena, B.
    Hernandez, S.
    Sanabrais, M. A.
    BIPOLAR DISORDERS, 2018, 20 : 12 - 12